3R*,4R*)-1-(4-Chlorophenyl)-4-[2-hydroxy-3-(morpholinomethyl) phenyl]-3-phenoxyazetidin-2-one

AKKURT, MEHMET; Jarrahpour, Aliasghar; Sharghi, Hashem; Badrabady, Seid; Buyukgungor, Orhan

doi:10.1107/s1600536811000675

3R,4R)-1-(4-Chlorophenyl)-4-[2-hydroxy-3-(morpholinomethyl) phenyl]-3-phenoxyazetidin-2-one

Atıf İçin Kopyala

AKKURT M., Jarrahpour A., Sharghi H., Badrabady S. A. T., Buyukgungor O.

ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, cilt.67, 2011 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 67
Basım Tarihi: 2011
Doi Numarası: 10.1107/s1600536811000675
Dergi Adı: ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Erciyes Üniversitesi Adresli: Evet

Özet

The beta-lactam ring of the title compound, C26H25ClN2O4, is nearly planar (r.m.s. deviation = 0.025 angstrom) and the morpholine ring adopts a chair conformation. The mean plane of the beta-lactam ring makes dihedral angles of 21.6 (4), 84.4 (4) and 33.7 (4)degrees with the two benzene rings and the phenyl ring, respectively. The conformation of the title compound is stabilized by intramolecular C-H center dot center dot center dot O and O-H center dot center dot center dot N interactions. The crystal structure features C-H center dot center dot center dot pi and aromatic pi-pi stacking interactions [centroid-centroid distances = 3.684 (4) and 3.883 (4) angstrom].